Salarius Pharmaceuticals
SLRX
SLRX
14 hedge funds and large institutions have $227K invested in Salarius Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
![]()
1
JPMorgan Chase & Co
New York
|
$0 |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$9.38K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$5.39K |